Zelluna ASA: Contemplated Private Placement and Retail Offering to Strengthen its Position Ahead of Initial Clinical Data

▤ Summary

Zelluna ASA plans a private placement and a retail offering to raise about NOK 45-50 million, with an additional retail tranche of up to EUR 1 million. The company wants to use the proceeds to fund its Phase 1 study, continue developing its TCR-NK platform, and support general corporate needs. Zelluna says the capital will also extend its runway as it approaches initial clinical data expected from mid-2026. The company already has roughly NOK 35 million in pre-commitments from existing shareholders and expects the raise to preserve strategic flexibility for future partnering and M&A activity.

$ Funding

▦ Linked Companies